Title:
USE OF P55PIK INHIBITOR IN PREPARATION OF DRUG FOR TREATING DRY EYE DISEASE
Document Type and Number:
WIPO Patent Application WO/2022/095765
Kind Code:
A1
Abstract:
Disclosed in the present invention is the use of a P55PIK inhibitor in the preparation of a drug for treating dry eye disease.
Inventors:
XIA XIANMIN (CN)
LI CHAOXING (CN)
LI CHAOXING (CN)
Application Number:
PCT/CN2021/126635
Publication Date:
May 12, 2022
Filing Date:
October 27, 2021
Export Citation:
Assignee:
WUHAN YICHENG BIOLOGICAL TECH CO LTD (CN)
International Classes:
A61P27/02; A61K38/10
Foreign References:
| CN112263672A | 2021-01-26 | |||
| CN111956781A | 2020-11-20 | |||
| CN110882228A | 2020-03-17 | |||
| CN111803619A | 2020-10-23 | |||
| CN104043102A | 2014-09-17 |
Other References:
ANONYMOUS: "A glimpse of the park", WUHAN YICHENG BIOTECHNOLOGY CO., LTD., 17 October 2019 (2019-10-17), XP055928012, Retrieved from the Internet
ZHU MEIJUAN; YANG HONGXIA; CHEN ZHEN; XIA XIANMIN; DENG QINQIN; SHEN YIN: "A cell-permeable peptide inhibitor of p55PIK signaling alleviates ocular inflammation in mouse models of uveitis", EXPERIMENTAL EYE RESEARCH, ACADEMIC PRESS LTD., LONDON., vol. 199, 8 August 2020 (2020-08-08), LONDON. , XP086286422, ISSN: 0014-4835, DOI: 10.1016/j.exer.2020.108180
See also references of EP 4241781A4
ZHU MEIJUAN; YANG HONGXIA; CHEN ZHEN; XIA XIANMIN; DENG QINQIN; SHEN YIN: "A cell-permeable peptide inhibitor of p55PIK signaling alleviates ocular inflammation in mouse models of uveitis", EXPERIMENTAL EYE RESEARCH, ACADEMIC PRESS LTD., LONDON., vol. 199, 8 August 2020 (2020-08-08), LONDON. , XP086286422, ISSN: 0014-4835, DOI: 10.1016/j.exer.2020.108180
See also references of EP 4241781A4
Attorney, Agent or Firm:
WUHAN GENUIRY INTELLECTUAL PROPERTY FIRM (GENERAL PARTNER) (CN)
Download PDF:
Previous Patent: PILLAR BUMP WITH NOBLE METAL SEED LAYER FOR ADVANCED HETEROGENEOUS INTEGRATION
Next Patent: LAMP
Next Patent: LAMP